Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 694)
Posted On: 12/10/2020 5:28:11 PM
Post# of 154916
Posted By: blafarm
Productive call, albeit with a fair amount of rehashing.

What really burned me was Dr.NP's "Right to Try" story about friend's family member who needed 3 doses to turn the corner and survive.

I will never forgive the FDA for limiting our CD12 trial to only 2 doses -- when we repeatedly asked for 3 or more doses.

How many more treatment arm patients in the CD12 would have survived with an additional one or two doses?

And assuming that trial has a favorable outcome, and the media starts reporting on our trial efficacy -- how much better would our story have been in terms of survival rates, if we had just been able to administer more than 2 doses?

This makes me very angry.

Lastly, regarding the LH protocol, I will only say that I am concerned that we are repeating the M/M CD10 mistake of having a subjective primary endpoint of fatigue. That's not how Dr.BP is handling it, and more than anyone else, he knows what he's doing.














(9)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site